BPA for xofigo and adempas
Ended Awarded Last action
- Contract number
- 36E79721A0002
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 1 $0 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling 0% used
- $45,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The BPA, valued at $45 million, is for the supply of two pharmaceutical products: Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer, and Adempas (riociguat) for the treatment of pulmonary arterial hypertension.
As the prime contractor, Bayer Healthcare Pharmaceuticals Inc. will provide these critical medications to the VA through its Federal Supply Schedule (FSS) contract with the parent company Bayer AG Pharmaceuticals Division. The contract supports the VA's efforts to deliver comprehensive healthcare services to veterans, particularly through the Veterans Integrated Service Network 22 facility in Long Beach, California. The BPA does not utilize any set-aside designations and has an ultimate completion date of October 5, 2025.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Xofigo for VA long beach radiology | Veterans Integrated Service Network 22 (VHA) | $0 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract 36E79721A0002?
36E79721A0002 was awarded to Bayer Healthcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 6, 2020.
How much is contract 36E79721A0002 worth?
Orders under 36E79721A0002 have obligated $0. 36E79721A0002's own ceiling is $45,000,000.
How many orders have been placed under contract 36E79721A0002?
1 order has been placed under 36E79721A0002, the latest on February 24, 2023.
Who can order from contract 36E79721A0002?
36E79721A0002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0002 under another contract?
Yes. 36E79721A0002 is a blanket purchase agreement under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0002 competed?
The extent of competition for 36E79721A0002 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV